NGM BIOPHARMACEUTICALS INC Restructuring Charges
NGM BIOPHARMACEUTICALS INC reported Restructuring Charges of $4.92 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2024-03-11
- NGM BIOPHARMACEUTICALS INC restructuring charges for the quarter ending 2023-12-31 was $0.00.
- NGM BIOPHARMACEUTICALS INC restructuring charges for the quarter ending 2023-09-30 was -$83.00K.
- NGM BIOPHARMACEUTICALS INC restructuring charges for the quarter ending 2023-06-30 was $4.90M.
- NGM BIOPHARMACEUTICALS INC restructuring charges for the quarter ending 2023-03-31 was $99.00K.
- NGM BIOPHARMACEUTICALS INC restructuring charges for fiscal 2023 was $4.92M.
| Period end | Restructuring Charges 1 month | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$83.00K derived: sum of 2 quarters · filed 2024-03-11 | $4.82M derived: sum of 3 quarters · filed 2024-03-11 | $4.92M 10-K · filed 2024-03-11 | ||
| 2023-09-30 | -$83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $4.82M derived: sum of 2 quarters · filed 2024-03-11 | $4.92M 10-Q · filed 2023-11-02 | |||
| 2023-06-30 | $4.90M 10-K · filed 2024-03-11 | $5.00M 10-Q · filed 2023-08-03 | $5.00M 10-Q · filed 2023-08-03 | |||
| 2023-04-30 | $5.00M 10-Q · filed 2023-08-03 | |||||
| 2023-03-31 | $99.00K derived: 10-K 12 month − 3 quarters · filed 2024-03-11 |